Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Diabetes Mellitus Type 2 and Non-alcoholic Fatty Liver Disease. The Effects of Metformin
oleh: V.I. Pankiv
Format: | Article |
---|---|
Diterbitkan: | Zaslavsky O.Yu. 2013-08-01 |
Deskripsi
Diabetes mellitus (DM) type 2 in clinical practice is often associated with non-alcoholic fatty liver disease (NAFLD), which has a number of clinical and morphological forms and develops in patients who do not abuse alcohol. The combination of DM type 2 and NAFLD is associated not only with a high risk of developing liver cirrhosis and hepatocellular carcinoma in these patients. Although all aspects of the etiology of NAFLD is not fully known, it is points to the role of insulin resistance in its development. This concept has facilitated a number of clinical studies using metformin as the insulin sensitizer in insulin-resistant patients with NAFLD. The findings emphasize the importance of metformin in the treatment of NAFLD in combination with a hypocaloric diet and the control of body weight. It is also reported about other tissue effects of metformin in NAFLD.